We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1

    Specific and selective anti-CB 1 antibodies are among the most powerful research tools to unravel the complex biological processes mediated by the CB 1 ...

    Leyre Echeazarra, Gontzal García del Caño, ... Joan Sallés in Histochemistry and Cell Biology
    Article Open access 27 August 2021
  2. Development, Comparison, and Qualification of Predictive Pharmaceutical Stability Models Using Independent Statistical Tools

    Purpose

    The predictive modeling approach to assess long-term stability performance of pharmaceuticals by using short-term accelerated stability is of...

    Mingkun Fu, Andrea Orta, ... Lakshminarasimhan Pranatharthiharan in Journal of Pharmaceutical Innovation
    Article 23 May 2024
  3. Fit-for-Purpose Validation and Establishment of Assay Acceptance and Reporting Criteria of Dendritic Cell Activation Assay Contributing to the Assessment of Immunogenicity Risk

    Validation of key analytical and functional performance characteristics of in vitro immunogenicity risk assessment assays increases our confidence in...

    Dilki Wickramarachchi, Gregory Steeno, ... Li Xue in The AAPS Journal
    Article 24 August 2020
  4. Microfluidic models of the neurovascular unit: a translational view

    The vasculature of the brain consists of specialized endothelial cells that form a blood-brain barrier (BBB). This barrier, in conjunction with...

    Nienke R. Wevers, Helga E. De Vries in Fluids and Barriers of the CNS
    Article Open access 27 November 2023
  5. Validation of Animal Models

    Animal research provides a major contribution to the discovery of new compounds and its mechanism of action. It also deals with the pharmacokinetics...
    Chapter 2022
  6. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment

    With an increasing need to incorporate new approach methodologies (NAMs) in chemical risk assessment and the concomitant need to phase out animal...

    Abdulkarim Najjar, Ans Punt, ... Nynke I. Kramer in Archives of Toxicology
    Article Open access 05 September 2022
  7. Macroscopic resting-state brain dynamics are best described by linear models

    It is typically assumed that large networks of neurons exhibit a large repertoire of nonlinear behaviours. Here we challenge this assumption by...

    Erfan Nozari, Maxwell A. Bertolero, ... Dani S. Bassett in Nature Biomedical Engineering
    Article Open access 11 December 2023
  8. Validating models of sensory conflict and perception for motion sickness prediction

    The human motion perception system has long been linked to motion sickness through state estimation conflict terms. However, to date, the extent to...

    Tugrul Irmak, Daan M. Pool, ... Riender Happee in Biological Cybernetics
    Article Open access 27 March 2023
  9. Low-dimensional models of single neurons: a review

    The classical Hodgkin–Huxley (HH) point-neuron model of action potential generation is four-dimensional. It consists of four ordinary differential...

    Ulises Chialva, Vicente González Boscá, Horacio G. Rotstein in Biological Cybernetics
    Article 15 April 2023
  10. Toxicokinetic Models

    Toxicokinetics describes by means of mathematical functions the time- and dose-dependent processes of absorption, distribution, and elimination of a...
    Johannes Georg Filser in Regulatory Toxicology
    Living reference work entry 2021
  11. Five multivariate Duchenne muscular dystrophy progression models bridging six-minute walk distance and MRI relaxometry of leg muscles

    The study aimed to provide quantitative information on the utilization of MRI transverse relaxation time constant (MRI-T 2 ) of leg muscles in DMD...

    Deok Yong Yoon, Michael J. Daniels, ... Sarah Kim in Journal of Pharmacokinetics and Pharmacodynamics
    Article 12 April 2024
  12. Toxicokinetic Models

    Toxicokinetics describes by means of mathematical functions the time- and dose-dependent processes of absorption, distribution, and elimination of a...
    Johannes Georg Filser in Regulatory Toxicology
    Reference work entry 2021
  13. Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol **nafoate to Quantify Batch-to-Batch Variability

    Advair Diskus is an essential treatment for asthma and chronic obstructive pulmonary disease. It is a dry powder inhaler with a combination of...

    Shuhui Li, Kairui Feng, ... Jogarao V. S. Gobburu in The AAPS Journal
    Article 26 April 2024
  14. Implementation of non-linear mixed effects models defined by fractional differential equations

    Fractional differential equations (FDEs), i.e. differential equations with derivatives of non-integer order, can describe certain experimental...

    Christos Kaikousidis, Aristides Dokoumetzidis in Journal of Pharmacokinetics and Pharmacodynamics
    Article Open access 21 March 2023
  15. Human Brain Penetration Prediction Using Scaling Approach from Animal Machine Learning Models

    Machine learning (ML) approaches have been applied to predicting drug pharmacokinetic properties. Previously, we predicted rat unbound...

    Siyu Liu, Yohei Kosugi in The AAPS Journal
    Article Open access 05 September 2023
  16. Assessing the performance of QSP models: biology as the driver for validation

    Validation of a quantitative model is a critical step in establishing confidence in the model’s suitability for whatever analysis it was designed....

    Fulya Akpinar Singh, Nasrin Afzal, ... Craig J. Thalhauser in Journal of Pharmacokinetics and Pharmacodynamics
    Article Open access 29 June 2023
  17. Towards a comprehensive assessment of QSP models: what would it take?

    Quantitative Systems Pharmacology (QSP) has emerged as a powerful ensemble of approaches aiming at develo** integrated mathematical and...

    Article 13 August 2022
  18. Adapted large language models can outperform medical experts in clinical text summarization

    Analyzing vast textual data and summarizing key information from electronic health records imposes a substantial burden on how clinicians allocate...

    Dave Van Veen, Cara Van Uden, ... Akshay S. Chaudhari in Nature Medicine
    Article 27 February 2024
  19. Best Practices for Integration of Dissolution Data into Physiologically Based Biopharmaceutics Models (PBBM): A Biopharmaceutics Modeling Scientist Perspective

    Dissolution is considered as a critical input into physiologically based biopharmaceutics models (PBBM) as it governs in vivo exposure. Despite many...

    Sivacharan Kollipara, Adithya Karthik Bhattiprolu, ... Siddharth Chachad in AAPS PharmSciTech
    Article 09 February 2023
  20. Generalizability of polygenic prediction models: how is the R2 defined on test data?

    Background

    Polygenic risk scores (PRS) quantify an individual’s genetic predisposition for different traits and are expected to play an increasingly...

    Christian Staerk, Hannah Klinkhammer, ... Andreas Mayr in BMC Medical Genomics
    Article Open access 16 May 2024
Did you find what you were looking for? Share feedback.